Beyond the Scale: GLP-1s Redefining Health Breakthroughs by 2026
Explore how GLP-1 receptor agonists are transcending obesity treatment, driving a 'Metabolic Renaissance' with breakthroughs in cardiovascular, renal, liver, and even neurological health by 2026.